Bayesian interim analysis in clinical trials
Related Experiment Video
Updated: Jul 4, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
1Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Abstract:
We propose a Bayesian approach to monitor clinical trials with clustered binary outcomes using multivariate probit models. Our monitoring is based on the calculated probability of the reduced incidence rate using a new treatment compared with the standard treatment greater than a target improvement under different prior scenarios for the treatment effect. We develop a Bayesian sampling algorithm for posterior inference allowing missing values in the outcomes. We illustrate our method using a published early trail of inhaled nitric oxide therapy in premature infants.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Comparing the Survival Analysis of Two or More Groups
Bioequivalence Data: Statistical Interpretation
Analysis of Population Pharmacokinetic Data
Clinical Trials: Overview